Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹5,553 Cr
Revenue (TTM)
₹756 Cr
Net Profit (TTM)
₹67 Cr
ROE
13.8 %
ROCE
14.8 %
P/E Ratio
82.8
P/B Ratio
5.7
Industry P/E
48.94
EV/EBITDA
31.1
Div. Yield
0 %
Debt to Equity
0.4
Book Value
₹643.5
EPS
₹76
Face value
2
Shares outstanding
100,340,717
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nephrocare Health Services
| 18.2 | -5.8 | 17.5 | -- | -- | -- | -- |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nephrocare Health Services
|
554.0 | 5,553.4 | 755.8 | 67.1 | -- | 13.8 | 82.8 | 5.7 |
| 251.9 | 616.0 | 230.1 | 23.5 | -- | 28.7 | 27.8 | 4.8 | |
| 1,346.9 | 22,583.1 | 2,662.8 | 533.1 | 22.9 | 24.1 | 42.7 | 8.8 | |
| 672.0 | 26,925.4 | 3,626.9 | 315.0 | 15.0 | 13.3 | 89.5 | 11.6 | |
| 605.1 | 1,960.4 | 766.3 | 80.5 | 15.7 | 8.9 | 24.4 | 2.1 | |
| 1,867.9 | 9,674.7 | 1,566.5 | 169.5 | 14.8 | 12.7 | 57.5 | 6.6 | |
| 285.6 | 929.3 | 1,231.3 | 29.1 | -4.7 | 4 | 35.7 | 1.4 | |
| 263.9 | 1,360.9 | 294.1 | 32.4 | 17.4 | 15.1 | 40.9 | 5.7 | |
| 372.7 | 5,934.5 | 792.3 | 135.5 | 23.5 | 26.4 | 43.1 | 8.9 | |
| 938.2 | 9,082.5 | 768.1 | 159.9 | 29.2 | 19.3 | 57 | 10.0 |
--
Incorporated
2009
Chairman
Vikram Vuppala
Managing Director
Vikram Vuppala
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Nephrocare Health Services Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Nephrocare Health Services Ltd is ₹553.95 (NSE) and ₹553.45 (BSE) as of 18-Mar-2026 IST. Nephrocare Health Services Ltd has given a return of --% in the last 1 years.
The P/E ratio of Nephrocare Health Services Ltd is 82.77 times as on 18-Mar-2026, a 69 premium to its peers’ median range of 48.94 times.
The P/B ratio of Nephrocare Health Services Ltd is 5.72 times as on 18-Mar-2026, a 18 discount to its peers’ median range of 6.98 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
The 52-week high and low of Nephrocare Health Services Ltd are Rs 616.00 and Rs 446.00 as of 19-Mar-2026.
Nephrocare Health Services Ltd has a market capitalisation of ₹ 5,553 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Nephrocare Health Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹38.70
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.